Use of botulinum toxin in chronic whiplash-associated disorder

Clinical Journal of Pain

Volumn 18, Issue 6 SUPPL., 2002, Pages

  Freund, Brian J ^a   Schwartz, Marvin ^a  

^a Crown Institute   (Canada)

Author keywords

Botulinum toxin; Cervical sprain; Neck pain; Whiplash; Whiplash associated disorders

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B; BUPIVACAINE; DILUENT; LIDOCAINE; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANALGESIA; CERVICAL SPINE INJURY; CHRONIC DISEASE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESPONSE; FATIGUE; HEADACHE; HUMAN; INJECTION PAIN; JOINT MOBILITY; MUSCLE SPASM; MUSCLE WEAKNESS; MYALGIA; NECK; NERVE SURGERY; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIOFREQUENCY; REVIEW; SPORT INJURY; SYMPTOM; TRAFFIC ACCIDENT; WHIPLASH INJURY; XEROSTOMIA;

BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEADACHE; HUMANS; INJECTIONS, INTRAMUSCULAR; MUSCULAR DISEASES; NECK PAIN; PAIN MEASUREMENT; WHIPLASH INJURIES;

EID: 0036839955     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-200211001-00008     Document Type: Review

References (34)

1. Evans RW. Some observations on whiplash injuries. Neurol Clin 1992;10:975-97.
2. Severy DM, Mathewson JH, Bechtol CO. Controlled automobile rear end collisions: An investigation of related engineering and medical phenomenon. Can Serv Med J 1955;11:727-59.
3. Pearce J. Post-traumatic syndrome and whiplash injuries or neck sprains. In: Kennard C, ed. Recent Advances in Clinical Neurology. 8th Ed. Edinburgh: Churchill Livingstone, 1995;7:133-49.
4. Siegmund GP, Myers MB, Bohnet HF, et al. Mechanical evidence of cervical facet capsule injury during whiplash: A cadaveric study using combined shear, compression and extension loading. Spine 2001;26:2095-101.
5. Deng YC. Anthropomorphic dummy neck modeling and injury considerations. Accid Anal Prev 1989;21:85-100.
6. Pearce J. Subtle cerebral lesions in chronic whiplash injuries? J Neurol Neurosurg Psychiatry 1993;56:1328-9.
7. Pearce J. MRI studies in whiplash injury: How do they relate to other investigations? Headache Q Curr Treat Res 1997;8:338-40.
8. Spitzer WOL, Skovron ML, Salmi LR, et al. Scientific monograph of the Quebec Task Force on whiplash-associated disorders: Redefining "whiplash" and its management. Spine 1995;20(8 Suppl):1S-73S.
9. Obelieniene D, Schrader H, Bovim G, et al. Pain after whiplash: A prospective controlled inception cohort study. J Neurol Neurosurg Psychiatry 1999;66:279-83.
10. Siebel GD, Bonk A, Edelmann M, et al. Whiplash injury. J Rheumatol 1999;26:1207-8. Letter.
11. Keidel M, Baume B, Ludecke C, et al. Prospective Analysis of Acute Sequelae Following Whiplash Injury. Vancouver, Canada: World Congress on Whiplash-Associated Disorders, 1999.
12. Partheni M, Miliaris G, Constantayannis C, et al. Whiplash injury. J Rheumatol 1999;26:1206-7. Letter.
13. Ferrari R, Russell AS. Epidemiology of whiplash. Ann Rheum Dis 2000;59:394-6. Letter.
14. Radanov BP. Epidemiology of whiplash. Ann Rheum Dis 2000;59:394-6. Letter.
15. Curatolo M, Petersen-Felix S, Arendt-Neilsen L, et al. Central hypersensitivity in chronic pain after whiplash injury. Clin J Pain 2001;17:306-15.
16. Lord S, Barnsley L, Bogduk N. Cervical zygapophyseal joint pain in whiplash. Spine 1993;7:355-71.
17. Lord SM, Barnsley L, Wallis BJ, et al. Chronic cervical zygapophyseal joint pain after whiplash: A placebo-controlled prevalence study. Spine 1996;21:1737-45.
18. Wiley AM, Lloyd J, Evans JG, et al. Musculoskeletal sequelae of whiplash injuries. Adv Q 1986;7:65-73.
19. Nederhand MJ, Izerman MJ, Hermens HJ, et al. Cervical muscle dysfunction in the chronic whiplash associated disorder grade II (WAD-II). Spine 2000;25:1938-43.
20. Percy J. Whiplash syndrome: A doctor's dilemma. Can J CME 1994;July:63-7.
21. Sutherland R. A crash course in whiplash management. Patient Care 1993;9:25-34.
22. McDonald GJ, Lord SM, Bogduk N. Long-term follow-up of patients treated with cervical radiofrequency neurotomy for chronic neck pain. Neurosurgery 1999;45:61-8.
23. Freund B, Schwartz M. Treatment of whiplash associated neck pain with botulinum toxin A: A pilot study. J Rheumatol 2000;27:481-4.
24. Wheeler AH, Goolkasian P, Gretz SS. A randomized double-blind, prospective study of botulinum toxin injection for refractory, unilateral cervicothoracic, paraspinal, myofascial pain syndrome. Spine 1998;23:1662-6.
25. Brin MF. Dosing, administration, and a treatment algorithm for use of botulinum toxin-A for adult onset spasticity. Muscle Nerve 1997;(Suppl 6):S208-21.
26. Pearce JM. Headaches in the whiplash syndrome. Spinal Cord 2001;39:228-33.
27. Opida CL. Open-label study of Myobloc™ (botulinum toxin type B) in the treatment of patients with post-whiplash headaches. Poster 204 presented at: International Conference 2002: Basic and Therapeutic Aspect of Botulinum and Tetanus Toxins: June, 2002; Hannover, Germany.
28. Aoki KR. A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice. Toxicon 2001;39:1815-20.
29. Bhaumik S, Behari M. Botulinum toxin A-injection for cervical dystonia. J Assoc Physicians India 1999;47:267-70.
30. Royal MA, Gordin V, Huebert JD, et al. Botulinum toxin type A in the treatment of refractory myofascial pain. Presented at: International Conference 1999: Basic and Therapeutic Aspect of Botulinum and Tetanus Toxins; June, 1999; Orlando, Fla.
31. Royal MA. The use of botulinum toxins in the management of pain and headache. Pain Pract 2001;1:215-35.
32. WE MOVE. Practical Considerations for the Clinical Use of Botulinum Toxin Type B: A self-study continuing medical education activity. February, 2002.
33. Caruthers A, Caruthers J. Cosmetic uses of botulinum A exotoxin. Adv Dermatol 1997;12:325-47.
34. Sterner Y, Lofgren M, Nyberg V, et al. Early interdisciplinary rehabilitation programme for whiplash associated disorders. Disabil Rehab 2001;23:422-9.